|
1.
|
A JemalF BrayMM CenterJ FerlayE WardD
FormanGlobal cancer statisticsCA Cancer J
Clin616990201110.3322/caac.20107
|
|
2.
|
K HagymásiZ TulassayEpidemiology risk
factors and molecular pathogenesis of primary liver cancerOrv
Hetil149541548200818343770
|
|
3.
|
B RamponeB SchiavoneG ConfuortoCurrent
management of hepatocellular cancerCurr Oncol
Rep12186192201010.1007/s11912-010-0094-3
|
|
4.
|
R LordA SuddlePJ RossEmerging strategies
in the treatment of advanced hepatocellular carcinoma: the role of
targeted therapiesInt J Clin
Pract65182188201110.1111/j.1742-1241.2010.02545.x21235699
|
|
5.
|
RS OliveriJ WetterslevC GluudTransarterial
(chemo) embolisation for unresectable hepatocellular
carcinomaCochrane Database Syst Rev16CD004787201121412886
|
|
6.
|
PJ WysockiTargeted therapy of
hepatocellular cancerExpert Opin Investig
Drugs19265274201010.1517/1354378090351411020074016
|
|
7.
|
Y YuQ LangZ ChenB LiC YuD ZhuX ZhaiC
LingThe efficacy for unresectable hepatocellular carcinoma may be
improved by transcatheter arterial chemoembolization in combination
with a traditional Chinese herbal medicine formula: a retrospective
studyCancer11551325138200910.1002/cncr.24567
|
|
8.
|
MB MengYL CuiYS GuanZ YingMH ZhengCK
YuanRM ZhangTraditional Chinese medicine plus transcatheter
arterial chemoembolization for unresectable hepatocellular
carcinomaJ Altern Complement
Med1410271042200810.1089/acm.2008.006018990050
|
|
9.
|
X ShuM McCullochH XiaoM BroffmanJ
GaoChinese herbal medicine and chemotherapy in the treatment of
hepatocellular carcinoma: a meta-analysis of randomized controlled
trialsIntegr Cancer
Ther4219229200510.1177/153473540527992716113029
|
|
10.
|
Q DuB HuKP ShenHM AnProgress in TCM
pathogenesis and treatment of liver cancerWorld J Integr Tradit
West Med58148172010
|
|
11.
|
FG HouCQ LingG ZhaoXM HeInvestigation of
clinical distribution of basic TCM Syndrome in primary hepatic
carcinomaShanghai J Tradit Chin Med3922232005
|
|
12.
|
YF WuSP WangJM SunJN WeiClinical
distribution and standards of TCM Syndrome of primary hepatic
carcinomaJ Shanxi Coll Tradit Chin Med821232007
|
|
13.
|
MQ PanPH ZengB PanRegularity of
traditional Chinese medicine in middle and advanced primary hepatic
carcinomaChinese Arch Tradit Chin Med21164116422003
|
|
14.
|
Q LiuYB ZhangCH MaXQ YueCQ LingAnalysis of
literature on therapeutic methods and medicines of traditional
Chinese medicine for primary liver cancerJ Chin Integr
Med3260262200510.3736/jcim2005040316009099
|
|
15.
|
M XiangZL GuWX ZhouCY GuoAnti-cancer
effects of extract of glossy privet fruit in vivoJiangsu Pharm Clin
Res1013152002
|
|
16.
|
L LiRL QiuG ChengY ShiY HanY GaoY LuThe
study on the anti-tumor effect of polysaccharides from glossy
privet fruit in vitro and in vivoChin Pharm Bull24161916222008
|
|
17.
|
Q DuB HuKP ShenA Survey of anti-cancer
effects of Chinese tonifying herbs in primary hepatic carcinomaJ
Chin Med Mater33151215162010
|
|
18.
|
SL YanCY HuangST WuMC YinOleanolic acid
and ursolic acid induce apoptosis in four human liver cancer cell
linesToxicol In
Vitro24842848201010.1016/j.tiv.2009.12.00820005942
|
|
19.
|
JM YangBB YangA ZhangJQ WangB ZhangThe
research and development of Polygounm cuspidatumActa Agric
Boreali-occidentalis Sinica131561592004
|
|
20.
|
L FengLF ZhangT YanJ JinWY TaoStudies on
active substance of anticancer effect in Polygonum
cuspidatumJ Chin Med Mater29689691200617059010
|
|
21.
|
D DelmasE SolaryN LatruffeResveratrol, a
phytochemical inducer of multiple cell death pathways: apoptosis,
autophagy and mitotic catastropheCurr Med
Chem1811001121201110.2174/09298671179502970821291372
|
|
22.
|
Z GaoMS XuTL BarnettCW XuResveratrol
induces cellular senescence with attenuated mono-ubiquitination of
histone H2B in glioma cellsBiochem Biophys Res
Commun407271276201110.1016/j.bbrc.2011.02.00821481687
|
|
23.
|
YL HsuPL KuoTF TzengSC SungMH YenLT LinCC
LinHuang-lian-jie-du-tang, a traditional Chinese medicine
prescription, induces cell-cycle arrest and apoptosis in human
liver cancer cells in vitro and in vivoJ Gastroenterol
Hepatol23e290e299200810.1111/j.1440-1746.2008.05390.x18522681
|
|
24.
|
B HuKP ShenHM AnY WuQ DuAqueous extract of
curcuma aromatica induces apoptosis and G2/M arrest in human colon
carcinoma LS-174-T cells independent of p53Cancer Biother
Radiopharm2697104201110.1089/cbr.2010.085321348775
|
|
25.
|
B HuHM AnKP ShenQ DuSenescence-inducing
effects of Chinese herbal medicine Tenglong Buzhong Decoction on
human colon carcinoma LS-174-T cells and the mechanismJ Chin Integr
Med810481052201010.3736/jcim2010110821078269
|
|
26.
|
YA LazebnikSH KaufmannS DesnoyersGG
PoirierWC EarnshawCleavage of poly(ADP-ribose)polymerase by a
proteinase with properties like
ICENature371346347199410.1038/371346a08090205
|
|
27.
|
JM BrownLD AttardiThe role of apoptosis in
cancer development and treatment responseNat Rev
Cancer5231237200515738985
|
|
28.
|
P MeierKH VousdenLucifer’s labyrinth - ten
years of path finding in cell deathMol Cell287467542007
|
|
29.
|
MV ChiantoreS VannucchiG ManginoZA
PercarioE AffabrisG FiorucciG RomeoSenescence and cell death
pathways and their role in cancer therapeutic outcomeCurr Med
Chem16287300200910.2174/09298670978700269119149578
|
|
30.
|
CA SchmittCellular senescence and cancer
treatmentBiochim Biophys Acta1775520200717027159
|
|
31.
|
JA EwaldJA DesotelleG WildingDF
JarrardTherapy-induced senescence in cancerJ Natl Cancer
Inst10215361546201010.1093/jnci/djq36420858887
|
|
32.
|
DA GewirtzSE HoltLW ElmoreAccelerated
senescence: an emerging role in tumor cell response to chemotherapy
and radiationBiochem
Pharmacol76947957200810.1016/j.bcp.2008.06.02418657518
|
|
33.
|
X DiRP ShiuIF NewshamDA GewirtzApoptosis,
autophagy, accelerated senescence and reactive oxygen in the
response of human breast tumor cells to adriamycinBiochem
Pharmacol7711391150200910.1016/j.bcp.2008.12.01619185564
|
|
34.
|
RH Te PoeleAL OkorokovL JardineJ
CummingsSP JoelDNA damage is able to induce senescence in tumor
cells in vitro and in vivoCancer Res6218761883200211912168
|
|
35.
|
Z HanW WeiS DunawayJW DarnowskiP
CalabresiJ SedivyEA HendricksonKV BalanP PantazisJH WycheRole of
p21 in apoptosis and senescence of human colon cancer cells treated
with camptothecinJ Biol
Chem2771715417160200210.1074/jbc.M11240120011877436
|
|
36.
|
C NardellaJG ClohessyA AlimontiPP
PandolfiPro-senescence therapy for cancer treatmentNat Rev
Cancer11503511201110.1038/nrc305721701512
|
|
37.
|
IB RoninsonTumor cell senescence in cancer
treatmentCancer Res6327052715200312782571
|
|
38.
|
GP DimriWhat has senescence got to do with
cancerCancer Cell7505512200510.1016/j.ccr.2005.05.02515950900
|
|
39.
|
D LodyginA MenssenH HermekingInduction of
the Cdk inhibitor p21 by LY83583 inhibits tumor cell proliferation
in a p53-independent mannerJ Clin
Invest11017171727200210.1172/JCI021658812464677
|
|
40.
|
UM ChangCH LiLI LinCP HuangLS KanSB
LinGanoderiol F, a ganoderma triterpene, induces senescence in
hepatoma HepG2 cellsLife
Sci7911291139200610.1016/j.lfs.2006.03.02716635496
|
|
41.
|
R XingW LiJ CuiJ ZhangB KangY WangZ WangS
LiuY LuGastrokine 1 induces senescence through p16/Rb pathway
activation in gastric cancer cellsGutJune142011(E-pub ahead of
print).
|
